Orchestra BioMed Holdings (OBIO) 10% owner Rtw Investments bought 50,000 shares for $126K at $2.53
Insider transactions reported
Rtw Investments, Lp (10% owner at Orchestra BioMed Holdings Inc., OBIO) reported that they bought 50,000 shares for $126K at $2.53 on Apr 29, 2025. After these transactions the filing shows 8,256,163 shares held indirectly (Please see footnote).
- Reporting person
- Rtw Investments, Lp
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Apr 29, 2025 | Open-market purchase (P) | Common Stock1 | +50,000 | $2.53 | $126K | 8,256,163 indirect |
Holdings before and after
- Common Stock: 8,206,163 to 8,256,163 indirect, Please see footnote
Footnotes from the filing
- 1. Held by certain affiliated funds managed by RTW Investments, LP ( RTW ). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The reporting persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Rtw Investments report in this OBIO Form 4?
Rtw Investments, Lp (10% owner at Orchestra BioMed Holdings Inc., OBIO) reported that they bought 50,000 shares for $126K at $2.53 on Apr 29, 2025. After these transactions the filing shows 8,256,163 shares held indirectly (Please see footnote).
How many OBIO shares does Rtw Investments hold after this filing?
The filing shows 8,256,163 shares held indirectly (Please see footnote) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Ask Ellis, your AI research assistant, about this story
Historical context for OBIO
Earlier insider filings at OBIO
- Apr 5, 2025Officer Hochman David P was granted 98,333 shares, increasing direct ownership by 20% to 579,498 units (SEC Form 4)
- Apr 5, 2025SEC Form 4 filed by Principal Accounting Officer Aiello Joshua
- Apr 5, 2025Officer Sherman Darren was granted 115,708 shares, increasing direct ownership by 16% to 849,680 units (SEC Form 4)
- Apr 5, 2025Chief Financial Officer Taylor Andrew Lawrence was granted 84,000 shares, increasing direct ownership by 24% to 428,960 units (SEC Form 4)
- Mar 29, 2025Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 278 shares, decreasing direct ownership by 6% to 4,722 units (SEC Form 4)
Keep researching OBIO
- OBIO insider tradesEvery buy and sale reported by Orchestra BioMed Holdings Inc. officers, directors and large holders.
- What is Insider buying?Purchases of a company's stock by its officers, directors or 10% holders, reported to the SEC on Form 4 and watched as a signal of insider confidence.
- How to track insider buyingInsider buying is tracked through SEC Form 4 code P filings. Learn how to find open-market purchases, spot cluster buys and judge which insider trades carry real signal.
- Insider trading trackerThe latest insider buys and sales across every stock.
- OBIO earnings historyPast Orchestra BioMed Holdings Inc. earnings releases, newest first.
- OBIO financial statementsRevenue, profit, cash flow and balance sheet from Orchestra BioMed Holdings Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Follow OBIO and get a push notification the moment its next story breaks.